# Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation

> **NCT03777605** · PHASE4 · UNKNOWN · sponsor: **Kolding Sygehus** · enrollment: 10 (estimated)

## Conditions studied

- Angina Pectoris

## Interventions

- **DRUG:** Nitroglycerin 0.4 MG

## Key facts

- **NCT ID:** NCT03777605
- **Lead sponsor:** Kolding Sygehus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-23
- **Primary completion:** 2020-12-05
- **Final completion:** 2020-12-23
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03777605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03777605, "Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03777605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*